logo

Evoke Pharma, Inc. (EVOK)



Trade EVOK now with
  Date
  Headline
5/20/2020 8:40:29 AM Evoke Pharma Receives FDA Conditional Acceptance Of Gimoti Brand Name
1/27/2020 8:41:49 AM Evoke Pharma Gets Notice Of Allowance From USPTO For Nasal Spray Product Gimoti
1/23/2020 8:45:18 AM Evoke Enters Commercialization Agreement With EVERSANA Life Sciences For Gimoti
12/20/2019 8:39:17 AM Evoke Resubmits Gimoti NDA To FDA
6/27/2019 8:45:54 AM Evoke Submits Type A Meeting Request To FDA To Discuss CRL On Gimoti
6/27/2019 8:34:05 AM Evoke Pharma Requests Type A FDA Meeting To Plan For Resubmission Of Gimoti NDA
4/2/2019 6:03:40 AM Evoke Pharma Receives Complete Response Letter And Recommendations To Address Deficiencies From FDA For Gimoti NDA
3/6/2019 8:40:24 AM Evoke Pharm Q4 Net Loss $1.8 Mln Or $0.10/shr Vs. Net Loss Of $0.3 Mln Or $0.02/shr Prior Year
8/16/2018 8:33:03 AM Evoke Pharma’s Gimoti NDA Accepted For FDA Review
6/4/2018 7:34:43 AM Evoke Announces FDA Submission Of NDA For Gimoti
5/14/2018 6:32:21 AM Evoke Pharma Q1 Net Loss $2.0 Mln Or $0.13/Shr Vs Loss $5.1 Mln Or $0.37/Shr Last Year
5/10/2018 7:35:49 AM Evoke Pharma Says Granted Gender Specific Patent For Gimoti In Mexico
3/26/2018 7:31:41 AM Evoke Announces Deal With Mallinckrodt To Amend Milestone Payments; Cash Runway Extended To January 2019